Marinus Pharmaceuticals Inc (MRNS)
1.33
+0.03
(+2.31%)
USD |
NASDAQ |
May 17, 16:00
1.33
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals 1 Year Total Returns (Daily): -84.00% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -84.00% |
May 16, 2024 | -84.72% |
May 15, 2024 | -84.57% |
May 14, 2024 | -84.74% |
May 13, 2024 | -84.62% |
May 10, 2024 | -86.12% |
May 09, 2024 | -85.08% |
May 08, 2024 | -84.39% |
May 07, 2024 | -82.42% |
May 06, 2024 | -83.43% |
May 03, 2024 | -83.22% |
May 02, 2024 | -83.54% |
May 01, 2024 | -83.89% |
April 30, 2024 | -84.51% |
April 29, 2024 | -84.62% |
April 26, 2024 | -83.03% |
April 25, 2024 | -82.66% |
April 24, 2024 | -82.80% |
April 23, 2024 | -82.22% |
April 22, 2024 | -81.79% |
April 19, 2024 | -82.92% |
April 18, 2024 | -82.83% |
April 17, 2024 | -82.02% |
April 16, 2024 | -83.76% |
April 15, 2024 | -82.41% |
Date | Value |
---|---|
April 12, 2024 | 6.67% |
April 11, 2024 | 12.82% |
April 10, 2024 | 15.24% |
April 09, 2024 | 27.16% |
April 08, 2024 | 24.43% |
April 05, 2024 | 21.68% |
April 04, 2024 | 29.55% |
April 03, 2024 | 24.29% |
April 02, 2024 | 28.55% |
April 01, 2024 | 30.00% |
March 28, 2024 | 44.87% |
March 27, 2024 | 41.37% |
March 26, 2024 | 41.77% |
March 25, 2024 | 44.03% |
March 22, 2024 | 46.83% |
March 21, 2024 | 44.39% |
March 20, 2024 | 32.36% |
March 19, 2024 | 36.97% |
March 18, 2024 | 32.84% |
March 15, 2024 | 41.84% |
March 14, 2024 | 28.22% |
March 13, 2024 | 44.79% |
March 12, 2024 | 45.91% |
March 11, 2024 | 33.33% |
March 08, 2024 | 19.35% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.05%
Minimum
Jul 24 2019
269.5%
Maximum
Nov 20 2020
5.26%
Average
-19.65%
Median
1 Year Total Returns (Daily) Benchmarks
Pfizer Inc | -17.67% |
ACADIA Pharmaceuticals Inc | -34.79% |
Alnylam Pharmaceuticals Inc | -22.68% |
Regeneron Pharmaceuticals Inc | 31.04% |
Actinium Pharmaceuticals Inc | 16.81% |